By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • The Wire
  • Health Topics
  • Podcast & Media
  • GMJ Articles
  • Perspectives
  • Policy & Systems
  • Dictionary
  • Practice
  • Research Digest
  • Read the Journal →
  • Latest News
    • GMJ Briefs
  • The Wire
  • Health Topics
  • Podcast & Media
    • GMJ Audio
    • GMJ Videos
    • Podcast & Media
    • Podcast Episodes
  • GMJ Articles
    • Vol. 1 Issue 3 (2026)
    • Public Health Dictionary — Supplement Edition
    • IAP Legacy Series
    • Read Full Journal (gmj.ge) →
    • Pre-Launch Articles (2025)
    • Vol. 1 Issue 1 (2026)
    • Vol. 1 Issue 2 (2026)
  • Perspectives
    • Editorial
    • Explainers
    • Letters
    • Voices
  • Policy & Systems
    • Global Health
    • Health Policy
    • Migration & Health
    • Quality & Safety
    • Work & Health
  • Dictionary
    • Our Story: 20 Years in the Making
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Practice
    • Case Discussions
    • Clinical Updates
    • Pharmacy & Prescribing
  • Research Digest
    • Data & Numbers
    • Georgian Research
    • New Studies
  • Read the Journal →
Follow US
GMJ News > GMJ Briefs > 500 mg Daily: What Taurine Safety Data Actually Reveals

500 mg Daily: What Taurine Safety Data Actually Reveals

GMJ
Last updated: 09/08/2026 21:30
By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Share
1 Min Read
Molecular structure and cellular metabolism illustration showing taurine function
Recent headlines claimed taurine fuels cancer, but a Nature study of leukemia cells in mice was misrepresented. Taurine was not shown to cause cancer; rather, existing cancer cells can use it as a metabolic substrate—a mechanism distinct from dietary risk. — A scientist working in a laboratory.jpg by Stanford ENERGY, Video by Mark Shwartz / CC BY 2.5 via Wikimedia Commons (CC BY 2.5)
SHARE
1 min read|125 words

The typical daily intake of taurine from diet and supplements in clinical practice stands at approximately 500 mg—a figure supported by decades of human safety data showing no established link to cancer risk. Taurine is a conditionally essential amino-acid-like molecule synthesized naturally by the body and obtained from common foods including meat, fish, and eggs. Despite widespread consumption and extensive research into its physiological roles, epidemiological evidence does not support claims that dietary taurine increases cancer incidence. The recent laboratory findings regarding cancer cell metabolism should not overshadow the substantial body of human safety evidence accumulated over decades. Health professionals and patients should critically evaluate whether sensational headlines align with the long-term safety profile demonstrated in clinical populations. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Taurine and Cancer: Separating Laboratory Findings from Dietary Risk →

Related reference
  • Taurine · Ingredient
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze, MD, MPH, PhD
Follow:
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Digital Therapy Platform Cuts Depression and Anxiety in Dementia Caregivers by Six Months

Researchers at the University of East Anglia have shown that a mobile-delivered…

Fermented Foods and Gut Health: Why Microbiome Science is Reshaping Clinical Practice

Rising colorectal cancer in young adults has sparked clinical interest in fermented…

Dementia risk factors vary dramatically by country, USC study of 214,000 adults reveals

A USC-led study of 214,000 older adults across 14 countries finds that…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Illustration of suicide prevention pyramid showing population-level and targeted clinical interventions

Population Awareness Alone Falls Short: Why Male Suicide Prevention Demands Dual-Track Strategy

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
22/09/2026
UK pharmaceutical manufacturing facility with MHRA regulatory approval documentation

Three Critical Healthcare Benefits from UK’s Pharmaceutical Licensing Expansion

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
07/07/2026
Clinical trial concept showing shingles vaccination pathway to dementia prevention research

What Clinicians and Patients Should Know About Shingles Vaccination and Dementia Prevention

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
12/08/2026
Chart comparing diagnostic sensitivity of B12 tests: methylmalonic acid at 98.4% versus CBC screening at 28%

The Hidden Epidemic: Normal Blood Tests Mask B12 Deficiency in Nearly 1 in 3 Patients

By
Prof. Giorgi Pkhakadze, MD, MPH, PhD
03/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Accreditation Canada in Georgia
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?